Review on Neuromyelitis Optica Spectrum Disorder Treatment

Created using ChatSlide

This presentation delves into neuromyelitis optica spectrum disorder (NMOSD), highlighting its impact and the role of AQP4-IgG antibodies. We will explore our cohort study's methodology, detailing participant demographics and treatment categorisation. Key findings include relapse statistics, safety outcomes, and event-free probabilities, leading to a thorough discussion on efficacy and safety. We'll also address study limitations, such as design constraints and sample size impact. Concluding...